Loss of core-fucosylation of SPARC impairs collagen binding and contributes to COPD

Cell Mol Life Sci. 2022 Jun 7;79(7):348. doi: 10.1007/s00018-022-04381-4.

Abstract

Chronic obstructive pulmonary disease (COPD) is a progressive lung disease with high morbidity and mortality worldwide. Although several mechanisms to account for deleterious immune effects were proposed, molecular description for the underlying alveolar structural alterations for COPD is lacking. Here, silencing of α1,6-fucosyltransferase (Fut8), the enzyme for core-fucosylation and highly expressed in lung stem cells, resulted in alveolar structural changes in lung organoids, recapitulating COPD. Site-specific mass spectrometry analysis demonstrated that the secreted protein acidic and rich in cysteine (SPARC), which binds collagen, contains a core-fucosylation site in its VCSNDNcfK glycopeptide. Biacore assay showed markedly reduced collagen binding of SPARC lacking core fucosylation. Molecular dynamics analysis revealed that core fucosylation of SPARC-induced dynamic conformational changes in its N-glycan, allowing terminal galactose and N-acetylglucosamine to interact with K150, P261 and H264 residues, thereby promoting collagen binding. Site-specific mutagenesis of these residues also resulted in low affinity for collagen binding. Moreover, loss of collagen and decline of core fucosylation were observed in COPD lung tissues. These findings provide a new mechanistic insight into the role of core fucosylation of SPARC in cell-matrix communication and contribution to the abnormal alveolar structures in COPD.

Keywords: COPD; Collagen; Core-fucosylation; Fut8; Matricellular protein; SPARC.

MeSH terms

  • Collagen / metabolism
  • Fucosyltransferases / genetics
  • Fucosyltransferases / metabolism
  • Glycosylation
  • Humans
  • Osteonectin* / genetics
  • Osteonectin* / metabolism
  • Pulmonary Disease, Chronic Obstructive* / genetics

Substances

  • Osteonectin
  • SPARC protein, human
  • Collagen
  • Fucosyltransferases